160 related articles for article (PubMed ID: 37361540)
21. MicroRNA-21 stimulates gastric cancer growth and invasion by inhibiting the tumor suppressor effects of programmed cell death protein 4 and phosphatase and tensin homolog.
Li L; Zhou L; Li Y; Lin S; Tomuleasa C
J BUON; 2014; 19(1):228-36. PubMed ID: 24659669
[TBL] [Abstract][Full Text] [Related]
22. Serum miR-375 for Diagnostic and Prognostic Purposes in Medullary Thyroid Carcinoma.
Censi S; Bertazza L; Piva I; Manso J; Benna C; Iacobone M; Mondin A; Plebani M; Faggian D; Galuppini F; Pennelli G; Barollo S; Mian C
Front Endocrinol (Lausanne); 2021; 12():647369. PubMed ID: 33854485
[TBL] [Abstract][Full Text] [Related]
23. Genetics of medullary thyroid cancer: An overview.
Accardo G; Conzo G; Esposito D; Gambardella C; Mazzella M; Castaldo F; Di Donna C; Polistena A; Avenia N; Colantuoni V; Giugliano D; Pasquali D
Int J Surg; 2017 May; 41 Suppl 1():S2-S6. PubMed ID: 28506408
[TBL] [Abstract][Full Text] [Related]
24. Circulating miR-26b-5p and miR-451a as diagnostic biomarkers in medullary thyroid carcinoma patients.
Besharat ZM; Trocchianesi S; Verrienti A; Ciampi R; Cantara S; Romei C; Sabato C; Noviello TMR; Po A; Citarella A; Caruso FP; Panariello I; Gianno F; Carpino G; Gaudio E; Chiacchiarini M; Masuelli L; Sponziello M; Pecce V; Ramone T; Maino F; Dotta F; Ceccarelli M; Pezzullo L; Durante C; Castagna MG; Elisei R; Ferretti E
J Endocrinol Invest; 2023 Dec; 46(12):2583-2599. PubMed ID: 37286863
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological and prognostic significance of PDCD4 and microRNA-21 in human gastric cancer.
Motoyama K; Inoue H; Mimori K; Tanaka F; Kojima K; Uetake H; Sugihara K; Mori M
Int J Oncol; 2010 May; 36(5):1089-95. PubMed ID: 20372781
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo.
Gaur AB; Holbeck SL; Colburn NH; Israel MA
Neuro Oncol; 2011 Jun; 13(6):580-90. PubMed ID: 21636706
[TBL] [Abstract][Full Text] [Related]
27. A Feedback Loop between MicroRNA 155 (miR-155), Programmed Cell Death 4, and Activation Protein 1 Modulates the Expression of miR-155 and Tumorigenesis in Tongue Cancer.
Zargar S; Tomar V; Shyamsundar V; Vijayalakshmi R; Somasundaram K; Karunagaran D
Mol Cell Biol; 2019 Mar; 39(6):. PubMed ID: 30617160
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-182 promotes cell growth, invasion, and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas.
Wang YQ; Guo RD; Guo RM; Sheng W; Yin LR
J Cell Biochem; 2013 Jul; 114(7):1464-73. PubMed ID: 23296900
[TBL] [Abstract][Full Text] [Related]
29. PDCD4 expression in thyroid neoplasia.
Pennelli G; Fassan M; Mian C; Pizzi M; Balistreri M; Barollo S; Galuppini F; Guzzardo V; Pelizzo M; Rugge M
Virchows Arch; 2013 Jan; 462(1):95-100. PubMed ID: 23212265
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-183 promotes proliferation and invasion in oesophageal squamous cell carcinoma by targeting programmed cell death 4.
Ren LH; Chen WX; Li S; He XY; Zhang ZM; Li M; Cao RS; Hao B; Zhang HJ; Qiu HQ; Shi RH
Br J Cancer; 2014 Nov; 111(10):2003-13. PubMed ID: 25211657
[TBL] [Abstract][Full Text] [Related]
31. An investigation on the expression of miRNAs including miR-144 and miR-34a in plasma samples of RET-positive and RET-negative medullar thyroid carcinoma patients.
Shabani N; Sheikholeslami S; Paryan M; Zarif Yeganeh M; Tavangar SM; Azizi F; Mohammadi-Yeganeh S; Hedayati M
J Cell Physiol; 2020 Feb; 235(2):1366-1373. PubMed ID: 31297834
[TBL] [Abstract][Full Text] [Related]
32. Non-Specific Blocking of miR-17-5p Guide Strand in Triple Negative Breast Cancer Cells by Amplifying Passenger Strand Activity.
Jin YY; Andrade J; Wickstrom E
PLoS One; 2015; 10(12):e0142574. PubMed ID: 26629823
[TBL] [Abstract][Full Text] [Related]
33. Vandetanib and cabozantinib potentiate mitochondria-targeted agents to suppress medullary thyroid carcinoma cells.
Starenki D; Hong SK; Wu PK; Park JI
Cancer Biol Ther; 2017 Jul; 18(7):473-483. PubMed ID: 28475408
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis.
Chusorn P; Namwat N; Loilome W; Techasen A; Pairojkul C; Khuntikeo N; Dechakhamphu A; Talabnin C; Chan-On W; Ong CK; Teh BT; Yongvanit P
Tumour Biol; 2013 Jun; 34(3):1579-88. PubMed ID: 23417858
[TBL] [Abstract][Full Text] [Related]
35. miRNA-21 regulates arsenic-induced anti-leukemia activity in myelogenous cell lines.
Gu J; Zhu X; Li Y; Dong D; Yao J; Lin C; Huang K; Hu H; Fei J
Med Oncol; 2011 Mar; 28(1):211-8. PubMed ID: 20143188
[TBL] [Abstract][Full Text] [Related]
36. Increased therapeutic effect on medullary thyroid cancer using a combination of radiation and tyrosine kinase inhibitors.
Sandblom V; Spetz J; Shubbar E; Montelius M; Ståhl I; Swanpalmer J; Nilsson O; Forssell-Aronsson E
PLoS One; 2020; 15(5):e0233720. PubMed ID: 32459817
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor PDCD4 and promotes cell transformation, proliferation, and metastasis in renal cell carcinoma.
Li X; Xin S; He Z; Che X; Wang J; Xiao X; Chen J; Song X
Cell Physiol Biochem; 2014; 33(6):1631-42. PubMed ID: 24902663
[TBL] [Abstract][Full Text] [Related]
38. Medullary Thyroid Carcinoma: Recent Advances Including MicroRNA Expression.
Chu YH; Lloyd RV
Endocr Pathol; 2016 Dec; 27(4):312-324. PubMed ID: 27539727
[TBL] [Abstract][Full Text] [Related]
39. Assessment of
Pishkari S; Hadavi R; Koochaki A; Razaviyan J; Paryan M; Hashemi M; Mohammadi-Yeganeh S
Horm Mol Biol Clin Investig; 2021 Mar; 42(3):265-271. PubMed ID: 33769725
[TBL] [Abstract][Full Text] [Related]
40. Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells.
Bourguignon LY; Spevak CC; Wong G; Xia W; Gilad E
J Biol Chem; 2009 Sep; 284(39):26533-46. PubMed ID: 19633292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
